sentence1
stringlengths
1.08k
96.5k
sentence2
stringlengths
51
966
labels
stringclasses
3 values
metadata
stringlengths
123
2.56k
Introduction Prone position is effective in mechanically ventilated patients to improve oxygenation. It is unknown if prone position affects gastric emptying and the ability of continued enteral feeding. Aim To determine tolerance of enteral feeding by measuring gastric residual volumes in enterally fed patients d...
Intervention: feeding in supine position Comparator: feeding in prone position Outcome: The mean cumulative dose of morphine/midazolam
-1
{"evidence_spans": [{"end": 10066, "start": 9890, "text": " sedated in either position. The mean cumulative dose of morphine/midazolam during 6 hours in the prone position was 15.8/11.8 mg compared with 9.7/7.3 mg during 6 hours in the"}], "id": "11552", "pmcid": "37407", "prompt_id": "11552", "split_group_id": "37407"...
The respiratory effects of dexmedetomidine were retrospectively examined in 33 postsurgical patients involved in a randomised, placebo-controlled trial after extubation in the intensive care unit (ICU). Morphine requirements were reduced by over 50% in patients receiving dexmedetomidine. There were no differences in re...
Intervention: dexmedetomidine Comparator: placebo Outcome: respiratory rates, oxygen saturations, arterial pH and arterial partial carbon dioxide tension (PaCO2)
0
{"evidence_spans": [{"end": 439, "start": 289, "text": "There were no differences in respiratory rates, oxygen saturations, arterial pH and arterial partial carbon dioxide tension (PaCO2) between the groups"}, {"end": 16491, "start": 16070, "text": "ith 24% (four out of 17) in the placebo group.\r\nThere were no statis...
The respiratory effects of dexmedetomidine were retrospectively examined in 33 postsurgical patients involved in a randomised, placebo-controlled trial after extubation in the intensive care unit (ICU). Morphine requirements were reduced by over 50% in patients receiving dexmedetomidine. There were no differences in re...
Intervention: dexmedetomidine Comparator: placebo Outcome: fractional inspired oxygen (FIO2)
1
{"evidence_spans": [{"end": 610, "start": 441, "text": "Interestingly the arterial partial oxygen tension (PaO2) : fractional inspired oxygen (FIO2) ratios were statistically significantly higher in the dexmedetomidine group."}, {"end": 16920, "start": 16620, "text": "aO2 : FIO2 ratio was used to compare oxygenation. T...
The respiratory effects of dexmedetomidine were retrospectively examined in 33 postsurgical patients involved in a randomised, placebo-controlled trial after extubation in the intensive care unit (ICU). Morphine requirements were reduced by over 50% in patients receiving dexmedetomidine. There were no differences in re...
Intervention: dexmedetomidine Comparator: placebo Outcome: Requirements for morphine
-1
{"evidence_spans": [{"end": 15906, "start": 15546, "text": "etween the placebo and dexmedetomidine groups. Requirements for morphine were reduced by half in patients receiving dexmedetomidine while intubated when compared with placebo (0.011 \u00b1 0.02 versus 0.022 \u00b1 0.02 mg/kg per h; P = 0.024), and this morphin...
Background Attrition, or dropout, is a problem faced by many online health interventions, potentially threatening the inferential value of online randomized controlled trials. Objective In the context of a randomized controlled trial of an online weight management intervention, where 85% of the baseline particip...
Intervention: mail Comparator: telephone Outcome: response rate
0
{"evidence_spans": [], "id": "11556", "pmcid": "1913938", "prompt_id": "11556", "split_group_id": "1913938", "votes": {"0": 2}}
Background Following the introduction of a computerised diabetes register in part of the northeast of England, care initially improved but then plateaued. We therefore enhanced the existing diabetes register to address these problems. The aim of the trial was to evaluate the effectiveness and efficiency of an area wid...
Intervention: area-wide, computerised diabetes register incorporating a full structured recall and individualised patient management system Comparator: standard structured and recall management system Outcome: cholesterol level in patients
-1
{"evidence_spans": [{"end": 1730, "start": 1599, "text": "evels, but the mean cholesterol level in patients from intervention practices was significantly lower (-0.15 mmol/l, 95% CI -0.25, "}, {"end": 1729, "start": 1603, "text": "s, but the mean cholesterol level in patients from intervention practices was significant...
Background Following the introduction of a computerised diabetes register in part of the northeast of England, care initially improved but then plateaued. We therefore enhanced the existing diabetes register to address these problems. The aim of the trial was to evaluate the effectiveness and efficiency of an area wid...
Intervention: area-wide, computerised diabetes register incorporating a full structured recall and individualised patient management system Comparator: standard structured and recall management system Outcome: mean HbA1c and blood pressure in patients
0
{"evidence_spans": [{"end": 1597, "start": 1546, "text": " 4.36). There was no difference in mean HbA1c or BP"}, {"end": 1598, "start": 1547, "text": "4.36). There was no difference in mean HbA1c or BP "}], "id": "11559", "pmcid": "1804280", "prompt_id": "11559", "split_group_id": "1804280", "votes": {"0": 2}}
Background Following the introduction of a computerised diabetes register in part of the northeast of England, care initially improved but then plateaued. We therefore enhanced the existing diabetes register to address these problems. The aim of the trial was to evaluate the effectiveness and efficiency of an area wid...
Intervention: area-wide, computerised diabetes register incorporating a full structured recall and individualised patient management system Comparator: standard structured and recall management system Outcome: the SF36 health status profile
0
{"evidence_spans": [{"end": 25371, "start": 25281, "text": "umber of people sampled, minus those known to be ineligible) (Figure 1). There were no sta"}, {"end": 25866, "start": 25580, "text": "Table 3. The differences between intervention and control groups were not statistically significant. There were no differences...
Background Following the introduction of a computerised diabetes register in part of the northeast of England, care initially improved but then plateaued. We therefore enhanced the existing diabetes register to address these problems. The aim of the trial was to evaluate the effectiveness and efficiency of an area wid...
Intervention: area-wide, computerised diabetes register incorporating a full structured recall and individualised patient management system Comparator: standard structured and recall management system Outcome: patient-reported outcomes or in patient-reported use of drugs, or uptake of health services
0
{"evidence_spans": [{"end": 1852, "start": 1731, "text": "0.06). There were no differences in patient-reported outcomes or in patient-reported use of drugs, or uptake of health se"}], "id": "11561", "pmcid": "1804280", "prompt_id": "11561", "split_group_id": "1804280", "votes": {"0": 2}}
Background Following the introduction of a computerised diabetes register in part of the northeast of England, care initially improved but then plateaued. We therefore enhanced the existing diabetes register to address these problems. The aim of the trial was to evaluate the effectiveness and efficiency of an area wid...
Intervention: area-wide, computerised diabetes register incorporating a full structured recall and individualised patient management system Comparator: standard structured and recall management system Outcome: The average cost per patient
0
{"evidence_spans": [{"end": 1958, "start": 1853, "text": "vices. The average cost per patient was not significantly different between the intervention and control "}, {"end": 28731, "start": 28561, "text": "1.45)\r\n-1.53 (-4.55, 1.48)\r\nSocial Function\r\n66.4 (29.6)\r\n64.0 (30.4)\r\n-2.71 (-7.00, 1.56)\r\n-2.71 (-7...
Background Following the introduction of a computerised diabetes register in part of the northeast of England, care initially improved but then plateaued. We therefore enhanced the existing diabetes register to address these problems. The aim of the trial was to evaluate the effectiveness and efficiency of an area wid...
Intervention: area-wide, computerised diabetes register incorporating a full structured recall and individualised patient management system Comparator: standard structured and recall management system Outcome: Frequency of at least one diabetes appointment, a foot check, receiving dietary advice, recording of blood pr...
1
{"evidence_spans": [{"end": 1546, "start": 1199, "text": "sults\r\nPatients in intervention practices were more likely to have at least one diabetes appointment recorded (OR 2.00, 95% CI 1.02, 3.91), to have a recording of a foot check (OR 1.87, 95% CI 1.09, 3.21), have a recording of receiving dietary advice (OR 2.77,...
Background Naturally acquired malaria immunity has many determinants and, in the absence of immunological markers of protection, studies assessing malaria incidence through clinical endpoints remain an approach to defining immunity acquisition. We investigated the role of age in disease incidence and the effects of ch...
Intervention: Deltaprim (3.125 mg of pyrimethamine plus 25 mg of dapsone) Comparator: placebo Outcome: the risk of severe malaria
0
{"evidence_spans": [{"end": 20300, "start": 20105, "text": "elative rate of having a severe malaria episode during the 4 y of follow-up. As with the pattern for clinical malaria, the rebound in the risk of severe malaria starts immediately after discontin"}, {"end": 20443, "start": 20300, "text": "uing prophylaxis, but...
Background Naturally acquired malaria immunity has many determinants and, in the absence of immunological markers of protection, studies assessing malaria incidence through clinical endpoints remain an approach to defining immunity acquisition. We investigated the role of age in disease incidence and the effects of ch...
Intervention: Deltaprim (3.125 mg of pyrimethamine plus 25 mg of dapsone) Comparator: placebo Outcome: severe malaria episodes
0
{"evidence_spans": [{"end": 1641, "start": 1465, "text": "9). By age 4 y, the cumulative rates of severe malaria, however, were slightly lower in chemosuppressed children (0.47 versus 0.59) (rate difference \u22120.12 [95% CI: \u22120.27 to 0.0"}], "id": "11570", "pmcid": "1950208", "prompt_id": "11570", "split_group_i...
Background Naturally acquired malaria immunity has many determinants and, in the absence of immunological markers of protection, studies assessing malaria incidence through clinical endpoints remain an approach to defining immunity acquisition. We investigated the role of age in disease incidence and the effects of ch...
Intervention: Deltaprim (3.125 mg of pyrimethamine plus 25 mg of dapsone) Comparator: placebo Outcome: risk of anaemia
0
{"evidence_spans": [{"end": 21072, "start": 20817, "text": "isk of Severe Anaemia\r\n\r\nFigure 2C shows the monthly incidence of severe anaemia. On average, by the age of 4 y, children will have had 1.12 (95% CI: 0.97 to 1.28) episodes of anaemia with a PCV of <25%; nearly half these episodes are in children aged les"...
Background Naturally acquired malaria immunity has many determinants and, in the absence of immunological markers of protection, studies assessing malaria incidence through clinical endpoints remain an approach to defining immunity acquisition. We investigated the role of age in disease incidence and the effects of ch...
Intervention: Deltaprim (3.125 mg of pyrimethamine plus 25 mg of dapsone) Comparator: placebo Outcome: hospital admissions during the first 4 y of life
0
{"evidence_spans": [{"end": 21710, "start": 21467, "text": " overall difference of \u22120.19 (95% CI: \u22120.40 to 0.01).\r\n\r\nRisk of Hospital Admissions\r\nChildren in the placebo group had, on average, 3.3 hospital admissions during the first 4 y of life (95% CI: 3.03 to 3.60), compared to 3.1 admissions (95% C"...
Background Response rates to surveys are declining and this threatens the validity and generalisability of their findings. We wanted to determine whether paper quality influences the response rate to postal surveys Methods A postal questionnaire was sent to all members of the British Society of Gynaecological Endo...
Intervention: questionnaire printed on standard quality paper Comparator: questionnaire printed on or high quality paper. Outcome: The response rate
0
{"evidence_spans": [{"end": 632, "start": 454, "text": "sults\r\nThe response rate for the recipients of high quality paper was 43/195 (22%) and 57/194 (29%) for standard quality paper (relative rate of response 0.75, 95% CI 0.33\u20131.05, "}, {"end": 3633, "start": 3355, "text": " (79% versus 75%). The response rate ...
Background Intracytoplasmic sperm injection (ICSI) is a component of infertility treatment often employed when conventional in vitro fertilization is unlikely to be successful. Despite good clinical results with ICSI, the procedure is typically associated with degeneration of a significant percentage (approximately 10...
Intervention: laser-assisted ICSI Comparator: conventional ICSI Outcome: Mature oocytes; Percent 2pn; Percent oocyte degeneration; Cell number, day 2; percent fragmentation, day 2; Cell number, day 3; Percent fragmentation, day 3; 16Embryos/ET, day 3; Percent compaction(b); percent blastocyst(b); percent compaction, ...
0
{"evidence_spans": [{"end": 1686, "start": 1566, "text": "sults\r\nNo significant differences between treatment and control groups were observed for any of the measured outcome var"}], "id": "11574", "pmcid": "1550249", "prompt_id": "11574", "split_group_id": "1550249", "votes": {"0": 2}}
Background Intracytoplasmic sperm injection (ICSI) is a component of infertility treatment often employed when conventional in vitro fertilization is unlikely to be successful. Despite good clinical results with ICSI, the procedure is typically associated with degeneration of a significant percentage (approximately 10...
Intervention: laser-assisted ICSI Comparator: conventional ICSI Outcome: cycles including oocytes with fragile zonae
-1
{"evidence_spans": [{"end": 17306, "start": 17170, "text": "2 and 3 was significantly greater than in cycles without any oocytes with a fragile zona (14.2% versus 6.8%, P = 0.018 and 17.0% versus "}, {"end": 17427, "start": 17170, "text": "2 and 3 was significantly greater than in cycles without any oocytes with a frag...
Background Intracytoplasmic sperm injection (ICSI) is a component of infertility treatment often employed when conventional in vitro fertilization is unlikely to be successful. Despite good clinical results with ICSI, the procedure is typically associated with degeneration of a significant percentage (approximately 10...
Intervention: laser-assisted ICSI Comparator: conventional ICSI Outcome: blastocyst formation rate
0
{"evidence_spans": [{"end": 13965, "start": 13497, "text": " measured outcome variables. The difference in blastocyst formation rates among the 14 cycles with blastocyst stage embryo transfer was nearly statistically significant at an alpha of 0.05. However, given that this probability estimate does not include an adju...
Objective To assess the efficacy of gatifloxacin versus cefixime in the treatment of uncomplicated culture positive enteric fever. Design A randomized, open-label, active control trial with two parallel arms. Setting Emergency Room and Outpatient Clinics in Patan Hospital, Lagankhel, Lalitpur, Nepal. Partic...
Intervention: Gatifloxacin 10 mg/kg, given once daily for 7 days Comparator: Cefixime 20 mg/kg/day given in two divided doses for 7 days Outcome: Median (95% confidence interval) fever clearance times
-1
{"evidence_spans": [{"end": 1335, "start": 1109, "text": "defined endpoints. Median (95% confidence interval) fever clearance times were 92 hours (84\u2013114 hours) for gatifloxacin recipients and 138 hours (105\u2013164 hours) for cefixime-treated patients (Hazard Ratio[95%CI]\u200a=\u200a2.171 [1.545"}], "id": "1157...
Objective To assess the efficacy of gatifloxacin versus cefixime in the treatment of uncomplicated culture positive enteric fever. Design A randomized, open-label, active control trial with two parallel arms. Setting Emergency Room and Outpatient Clinics in Patan Hospital, Lagankhel, Lalitpur, Nepal. Partic...
Intervention: Gatifloxacin 10 mg/kg, given once daily for 7 days Comparator: Cefixime 20 mg/kg/day given in two divided doses for 7 days Outcome: acute clinical failure
-1
{"evidence_spans": [{"end": 1558, "start": 1335, "text": "\u20133.051], p<0.0001). 19 out of 70 (27%) patients who completed the 7 day trial had acute clinical failure in the cefixime group as compared to 1 out of 88 patients (1%) in gatifloxacin group(Odds Ratio [95%CI]\u200a=\u200a0.031 [0.004"}, {"end": 1559, "start...
Objective To assess the efficacy of gatifloxacin versus cefixime in the treatment of uncomplicated culture positive enteric fever. Design A randomized, open-label, active control trial with two parallel arms. Setting Emergency Room and Outpatient Clinics in Patan Hospital, Lagankhel, Lalitpur, Nepal. Partic...
Intervention: Gatifloxacin 10 mg/kg, given once daily for 7 days Comparator: Cefixime 20 mg/kg/day given in two divided doses for 7 days Outcome: Relapse rates
-1
{"evidence_spans": [{"end": 23592, "start": 23453, "text": "ed to 5 out of 92 (5%) in the gatifloxacin group (OR[95%CI]\u200a=\u200a0.112 [0.041 \u2013 0.312], p<0.001).\r\n138 patients were evaluable for relapse; 20"}, {"end": 23662, "start": 23453, "text": "ed to 5 out of 92 (5%) in the gatifloxacin group (OR[95%CI]\...
Background This trial was conducted as part of a project that aims to enhance public understanding and use of research in decisions about healthcare by enabling viewers to participate in research and to follow the process, through television reports and on the web. Valerian is an herbal over-the-counter drug that is w...
Intervention: mailed valerian Comparator: placebo Outcome: minimally important improvement in self-reported sleep quality
0
{"evidence_spans": [{"end": 1181, "start": 898, "text": "dings\r\nFor the primary outcome of a minimally important improvement in self-reported sleep quality (\u22650.5 units on a 7 point scale), the difference between the valerian group (29%) and the placebo group (21%) was not statistically significant (difference 7....
Background This trial was conducted as part of a project that aims to enhance public understanding and use of research in decisions about healthcare by enabling viewers to participate in research and to follow the process, through television reports and on the web. Valerian is an herbal over-the-counter drug that is w...
Intervention: mailed valerian Comparator: placebo Outcome: perceived their sleep as better or much better
1
{"evidence_spans": [{"end": 1380, "start": 1282, "text": " 10.8) more participants in the valerian group perceived their sleep as better or much better (p\u200a="}, {"end": 28807, "start": 28569, "text": "ment of change\r\n(N\u200a=\u200a164)\r\n(N\u200a=\u200a164)\r\n\r\n\r\n- Much better or better (%)\r\n9.1\r\n3.7\r...
Background This trial was conducted as part of a project that aims to enhance public understanding and use of research in decisions about healthcare by enabling viewers to participate in research and to follow the process, through television reports and on the web. Valerian is an herbal over-the-counter drug that is w...
Intervention: mailed valerian Comparator: placebo Outcome: sleep onset latency
0
{"evidence_spans": [{"end": 29483, "start": 29247, "text": "re was no difference in the proportions in the two groups that indicated they were a little better. Chi-square tests showed that the participants, own perception of improvement on the global self-assessment did not correspond to improve"}], "id": "11587", "pmc...
Background Despite effective treatments, asthma outcomes remain suboptimal. Interest exists in complementary therapies, particularly in herbal remedies for asthma treatment, currently with inconclusive evidence of efficacy. The encapsulated botanical mixture AKL1 has anecdotal evidence of effectiveness in asthma. M...
Intervention: encapsulated botanical mixture AKL1 Comparator: placebo Outcome: Forced Expiratory Volume in 1 second; Peak Expiratory Flow;
0
{"evidence_spans": [{"end": 1504, "start": 1270, "text": "sults\r\nNo significant differences in lung function (active-placebo) were found (Forced Expiratory Volume in 1 second: mean difference [95% CI] = 0.01 [-0.12 to 0.14] L, p = 0.9. Peak Expiratory Flow: -4.08 [-35.03 to 26.89]. L/min, p "}], "id": "11588", "pmcid...
Background Despite effective treatments, asthma outcomes remain suboptimal. Interest exists in complementary therapies, particularly in herbal remedies for asthma treatment, currently with inconclusive evidence of efficacy. The encapsulated botanical mixture AKL1 has anecdotal evidence of effectiveness in asthma. M...
Intervention: encapsulated botanical mixture AKL1 Comparator: placebo Outcome: Asthma Control Questionnaire
0
{"evidence_spans": [{"end": 1900, "start": 1505, "text": " 0.8).\r\nTrends to clinical improvements favouring active treatment were however consistently seen in the patient-centered outcomes: Asthma Control Questionnaire mean difference (active \u2013 placebo) [95% CI] = -0.35 [-0.78 to 0.07], p = 0.10, Asthma Quality ...
Background Despite effective treatments, asthma outcomes remain suboptimal. Interest exists in complementary therapies, particularly in herbal remedies for asthma treatment, currently with inconclusive evidence of efficacy. The encapsulated botanical mixture AKL1 has anecdotal evidence of effectiveness in asthma. M...
Intervention: encapsulated botanical mixture AKL1 Comparator: placebo Outcome: Asthma Quality of Life Questionnaire
0
{"evidence_spans": [{"end": 1900, "start": 1505, "text": " 0.8).\r\nTrends to clinical improvements favouring active treatment were however consistently seen in the patient-centered outcomes: Asthma Control Questionnaire mean difference (active \u2013 placebo) [95% CI] = -0.35 [-0.78 to 0.07], p = 0.10, Asthma Quality ...
Background Despite effective treatments, asthma outcomes remain suboptimal. Interest exists in complementary therapies, particularly in herbal remedies for asthma treatment, currently with inconclusive evidence of efficacy. The encapsulated botanical mixture AKL1 has anecdotal evidence of effectiveness in asthma. M...
Intervention: encapsulated botanical mixture AKL1 Comparator: placebo Outcome: Leicester Cough Questionnaire
0
{"evidence_spans": [{"end": 1900, "start": 1505, "text": " 0.8).\r\nTrends to clinical improvements favouring active treatment were however consistently seen in the patient-centered outcomes: Asthma Control Questionnaire mean difference (active \u2013 placebo) [95% CI] = -0.35 [-0.78 to 0.07], p = 0.10, Asthma Quality ...
Background Tomorrow's physicians must learn to access, retrieve, integrate and apply current information into ambulatory patient encounters, yet few medical schools teach 'real time' information management. Methods We compared two groups of clerkship students' information management skills using a standardized pat...
Intervention: case-based discussions Comparator: standardized patient case Outcome: total scores
0
{"evidence_spans": [{"end": 10012, "start": 9900, "text": "he medication to avoid the interaction.\r\nThere was no difference in total scores between intervention and contro"}, {"end": 10013, "start": 9902, "text": " medication to avoid the interaction.\r\nThere was no difference in total scores between intervention an...
Background Tomorrow's physicians must learn to access, retrieve, integrate and apply current information into ambulatory patient encounters, yet few medical schools teach 'real time' information management. Methods We compared two groups of clerkship students' information management skills using a standardized pat...
Intervention: case-based discussions Comparator: standardized patient case Outcome: total scores in the third rotation scored
0
{"evidence_spans": [{"end": 10393, "start": 9902, "text": " medication to avoid the interaction.\r\nThere was no difference in total scores between intervention and control group students (13.4, 14.4, p = 0.12). However, students in both the intervention and control groups on the third rotation scored significantly hig...
Background Tomorrow's physicians must learn to access, retrieve, integrate and apply current information into ambulatory patient encounters, yet few medical schools teach 'real time' information management. Methods We compared two groups of clerkship students' information management skills using a standardized pat...
Intervention: case-based discussions Comparator: standardized patient case Outcome: examined the 13 technology items
0
{"evidence_spans": [{"end": 10393, "start": 10179, "text": "ation students. (13.6, 15, p = 0.038). However, when we examined the 13 technology items, there were no differences between intervention and control group scores (7.5, 7.9, p = 0.25) or between first and third rota"}], "id": "11594", "pmcid": "1420296", "promp...
Background Metabolic syndrome is a cluster of common cardiovascular risk factors that includes hypertension and insulin resistance. Hypertension and diabetes mellitus are frequent comorbidities and, like metabolic syndrome, increase the risk of cardiovascular events. Telmisartan, an antihypertensive agent with evidenc...
Intervention: telmisartan (80 mg) Comparator: losartan (50 mg) Outcome: free plasma glucose (FPG)
-1
{"evidence_spans": [{"end": 1106, "start": 939, "text": "sults\r\nTelmisartan, but not losartan, significantly (p < 0.05) reduced free plasma glucose, free plasma insulin, homeostasis model assessment of insulin resistance and"}, {"end": 10485, "start": 10322, "text": "a [1].\r\nChanges in metabolic parameters were obs...
Background Metabolic syndrome is a cluster of common cardiovascular risk factors that includes hypertension and insulin resistance. Hypertension and diabetes mellitus are frequent comorbidities and, like metabolic syndrome, increase the risk of cardiovascular events. Telmisartan, an antihypertensive agent with evidenc...
Intervention: telmisartan (80 mg) Comparator: losartan (50 mg) Outcome: HbA1c (glycosylated haemoglobin)
-1
{"evidence_spans": [{"end": 10484, "start": 10321, "text": "ia [1].\r\nChanges in metabolic parameters were observed at the end of treatment compared with baseline (table 2). Compared with losartan, telmisartan reduced FPG by"}], "id": "11598", "pmcid": "1174877", "prompt_id": "11598", "split_group_id": "1174877", "vot...
Objectives: To respond to the primary safety objective of the Perinatal HIV Prevention Trial 1 (PHPT-1) by studying the evolution of haematological parameters according to zidovudine exposure duration in HIV-1−infected pregnant women. Design: Multicenter, randomized, double-blind, controlled trial of different dur...
Intervention: Zidovudine prophylaxis initiation Comparator: placebo Outcome: haemoglobin level, leucocyte count, and absolute neutrophil count between 26 and 35 wk
-1
{"evidence_spans": [{"end": 1253, "start": 1012, "text": "load.\r\n\r\nResults:\r\nBetween 26 and 35 wk, haemoglobin, leucocytes, and absolute neutrophil counts decreased in zidovudine-exposed compared to unexposed women (mean difference [95% CI] \u22120.4 [\u22120.5 to \u22120.3], \u2212423 [\u2212703 to \u2212142], \...
Objectives: To respond to the primary safety objective of the Perinatal HIV Prevention Trial 1 (PHPT-1) by studying the evolution of haematological parameters according to zidovudine exposure duration in HIV-1−infected pregnant women. Design: Multicenter, randomized, double-blind, controlled trial of different dur...
Intervention: Zidovudine prophylaxis initiation Comparator: placebo Outcome: haemoglobin level, leucocyte count, and absolute neutrophil count at 35 wk gestation
1
{"evidence_spans": [{"end": 17988, "start": 17515, "text": "ological Measurements Evolution in HIV-Infected Pregnant Women According to Randomization Arms\r\nDuring the second period, between the 35-wk visit and delivery, after adjustment, the haemoglobin level, leucocyte count, and absolute neutrophil count increased ...
Cyclo-oxygenase-2 selective inhibitors are frequently used to manage osteoarthritis. We compared the analgesic efficacy of the novel cyclo-oxygenase-2 selective inhibitor lumiracoxib (Prexige®) versus placebo and celecoxib in patients with knee osteoarthritis. This seven day, double-blind, placebo and active comparator...
Intervention: lumiracoxib 400 mg/day Comparator: celecoxib 200 mg twice daily Outcome: time of analgesia
0
{"evidence_spans": [{"end": 1757, "start": 1635, "text": "The estimated difference between lumiracoxib and celecoxib 3\u20135 hours after the first dose was not significant (P = 0.185)."}], "id": "11605", "pmcid": "1526611", "prompt_id": "11605", "split_group_id": "1526611", "votes": {"0": 2}}
Cyclo-oxygenase-2 selective inhibitors are frequently used to manage osteoarthritis. We compared the analgesic efficacy of the novel cyclo-oxygenase-2 selective inhibitor lumiracoxib (Prexige®) versus placebo and celecoxib in patients with knee osteoarthritis. This seven day, double-blind, placebo and active comparator...
Intervention: celecoxib 200 mg twice daily Comparator: placebo Outcome: time of analgesia
0
{"evidence_spans": [{"end": 1842, "start": 1758, "text": "Celecoxib was not significantly different from placebo in this analysis (P = 0.069)."}], "id": "11606", "pmcid": "1526611", "prompt_id": "11606", "split_group_id": "1526611", "votes": {"0": 2}}
Cyclo-oxygenase-2 selective inhibitors are frequently used to manage osteoarthritis. We compared the analgesic efficacy of the novel cyclo-oxygenase-2 selective inhibitor lumiracoxib (Prexige®) versus placebo and celecoxib in patients with knee osteoarthritis. This seven day, double-blind, placebo and active comparator...
Intervention: celecoxib 200 mg twice daily Comparator: placebo Outcome: complete pain relief
0
{"evidence_spans": [{"end": 2195, "start": 1995, "text": " WOMAC\u2122 total and subscales improved for both active treatments versus placebo except for difficulty in performing daily activities, for which celecoxib just failed to achieve significance (P = 0.056)"}, {"end": 17929, "start": 17306, "text": " 2.0 mm, 95% ...
Cyclo-oxygenase-2 selective inhibitors are frequently used to manage osteoarthritis. We compared the analgesic efficacy of the novel cyclo-oxygenase-2 selective inhibitor lumiracoxib (Prexige®) versus placebo and celecoxib in patients with knee osteoarthritis. This seven day, double-blind, placebo and active comparator...
Intervention: celecoxib 200 mg twice daily, lumiracoxib 400 mg/day Comparator: placebo Outcome: The overall incidence of adverse events
0
{"evidence_spans": [{"end": 2500, "start": 2424, "text": "The overall incidence of adverse events was similar across treatment groups."}, {"end": 20811, "start": 20623, "text": "nt and were not associated with a specific body system.\r\nAdverse events assessed by the investigator as being possibly study drug related oc...
Background Previously, we have demonstrated a marked inhibition of codeine glucuronidation by diclofenac in human liver tissue homogenate. We therefore aimed to investigate whether diclofenac inhibits glucuronidation of codeine also in vivo in healthy volunteers. Methods In a randomised, placebo-controlled, double...
Intervention: 100 mg codeine phosphate plus 50 mg diclofenac sodium Comparator: codeine phosphate plus placebo Outcome: The total amount excreted of codeine and its metabolites
0
{"evidence_spans": [{"end": 20924, "start": 20732, "text": "rcodeine and morphine, of morphine to M-3-G, M-6-G and normorphine or renal clearance of codeine and its metabolites between the two treatments (Tables 3 and 4). The total amount excreted of c"}], "id": "11609", "pmcid": "101395", "prompt_id": "11609", "split_...
Background Previously, we have demonstrated a marked inhibition of codeine glucuronidation by diclofenac in human liver tissue homogenate. We therefore aimed to investigate whether diclofenac inhibits glucuronidation of codeine also in vivo in healthy volunteers. Methods In a randomised, placebo-controlled, double...
Intervention: 100 mg codeine phosphate plus 50 mg diclofenac sodium Comparator: codeine phosphate plus placebo Outcome: The area under the pain threshold-time, the area under the pain tolerance-time
0
{"evidence_spans": [{"end": 23490, "start": 23214, "text": "al administration of 50 mg diclofenac sodium together with 100 mg codeine phosphate (n = 12).\r\n\r\nmean (95% CI)\r\nCmax [nmol/ml]\r\n4.42 (3.77\u20135.06)\r\ntmax [h]\r\n1.73 (1.21\u20132.26)\r\nAUC [h nmol/ml]\r\n5.63 (4.77\u20136.50)\r\nt1/2 [h]\r\n0.97 (...
Background Previously, we have demonstrated a marked inhibition of codeine glucuronidation by diclofenac in human liver tissue homogenate. We therefore aimed to investigate whether diclofenac inhibits glucuronidation of codeine also in vivo in healthy volunteers. Methods In a randomised, placebo-controlled, double...
Intervention: 100 mg codeine phosphate plus 50 mg diclofenac sodium Comparator: codeine phosphate plus placebo Outcome: apparent oral clearance of codeine (CLo) , metabolic clearance of codeine to C-6-G, norcodeine and morphine, of morphine to M-3-G, M-6-G and normorphine or renal clearance of codeine and its metabolit...
0
{"evidence_spans": [{"end": 20731, "start": 20360, "text": "ne-3- and morphine-6-glucuronide after administration of codeine + placebo vs. codeine + diclofenac (Mean, SD, n= 12) \u25a1 codeine + placebo \u2666 codeine + diclofenac\r\nNo significant differences were observed in either the apparent oral clearance of code...
Background Previously, we have demonstrated a marked inhibition of codeine glucuronidation by diclofenac in human liver tissue homogenate. We therefore aimed to investigate whether diclofenac inhibits glucuronidation of codeine also in vivo in healthy volunteers. Methods In a randomised, placebo-controlled, double...
Intervention: 100 mg codeine phosphate plus 50 mg diclofenac sodium Comparator: codeine phosphate plus placebo Outcome: The total amount excreted of codeine and its metabolites excreted
0
{"evidence_spans": [{"end": 20924, "start": 20732, "text": "rcodeine and morphine, of morphine to M-3-G, M-6-G and normorphine or renal clearance of codeine and its metabolites between the two treatments (Tables 3 and 4). The total amount excreted of c"}, {"end": 21000, "start": 20924, "text": "odeine and its metabolit...
Introduction Chronic diseases such as cancer, cardiovascular disease, stroke, and diabetes are responsible for most deaths in the United States. Lifestyle factors — poor nutrition, sedentary living, and tobacco use — appear to play a prominent role in the development of many chronic diseases. This study determined the...
Intervention: therapeutic lifestyle-modification intervention Comparator: control Outcome: blood pressure medication
0
{"evidence_spans": [{"end": 19791, "start": 19619, "text": "icipants (13.8%) indicated a dosage decrease. There was not a significant difference in the use of blood pressure medication from baseline to 6 months between the intervent"}], "id": "11617", "pmcid": "1500954", "prompt_id": "11617", "split_group_id": "1500954...
Beginning in 1975, 78 patients with resected stage B and C colorectal carcinoma were randomly assigned (2:1) to receive either levamisole 2.5 mg kg-1 day-1 given for 2 days every week for 18 months or placebo therapy in the same schedule. Pretreatment characteristics (age, gender, disease site, CEA and stage) and the p...
Intervention: levamisole 2.5 mg kg-1 day-1 Comparator: placebo therapy in the same schedule Outcome: overall survival
-1
{"evidence_spans": [{"end": 711, "start": 586, "text": "Consequently, overall survival was somewhat greater in the placebo group than in the levamisole group, 68% vs 38% (P < 0.08)."}], "id": "11618", "pmcid": "1969447", "prompt_id": "11618", "split_group_id": "1969447", "votes": {"-1": 1}}
Beginning in 1975, 78 patients with resected stage B and C colorectal carcinoma were randomly assigned (2:1) to receive either levamisole 2.5 mg kg-1 day-1 given for 2 days every week for 18 months or placebo therapy in the same schedule. Pretreatment characteristics (age, gender, disease site, CEA and stage) and the p...
Intervention: levamisole 2.5 mg kg-1 day-1 Comparator: placebo therapy in the same schedule Outcome: patients surviving 5 years from randomisation
-1
{"evidence_spans": [{"end": 840, "start": 712, "text": "For patients surviving 5 years from randomisation, subsequent survival favoured placebo over levamisole (100% vs 57%; P < 0.03)."}], "id": "11619", "pmcid": "1969447", "prompt_id": "11619", "split_group_id": "1969447", "votes": {"-1": 2}}
Introduction Delayed gastric emptying and feed intolerance occur frequently in the critically ill. In these patients, gastric motor responses to nutrients are disturbed. Peptide YY (PYY) slows gastric emptying. The aim of this study was to determine fasting and nutrient-stimulated plasma PYY concentrations and their r...
Intervention: 60-minute duodenal infusion of Ensure® 1 and 2 kcal/minute Comparator: healthy subjects Outcome: Fasting PYY concentration
1
{"evidence_spans": [{"end": 1050, "start": 934, "text": "sults\r\nFasting PYY concentration was higher in patients (P < 0.05), particularly in those with feed intolerance (P <"}, {"end": 1325, "start": 1051, "text": "0.05). Plasma PYY concentrations were higher in patients during nutrient infusion (area under the curve...
Introduction Delayed gastric emptying and feed intolerance occur frequently in the critically ill. In these patients, gastric motor responses to nutrients are disturbed. Peptide YY (PYY) slows gastric emptying. The aim of this study was to determine fasting and nutrient-stimulated plasma PYY concentrations and their r...
Intervention: 60-minute duodenal infusion of Ensure® 1 kcal/minute Comparator: 60-minute duodenal infusion of Ensure® 2 kcal/minute Outcome: The magnitude of PYY elevation
1
{"evidence_spans": [{"end": 1505, "start": 1326, "text": "jects. The magnitude of PYY elevation was greater in patients during the 1 kcal/minute infusion (AUC: 441 \u00b1 153 versus 186 \u00b1 58 pmol/l.min, P < 0.05), but not the 2 kcal/minute in"}], "id": "11621", "pmcid": "1794491", "prompt_id": "11621", "split_grou...
Introduction Delayed gastric emptying and feed intolerance occur frequently in the critically ill. In these patients, gastric motor responses to nutrients are disturbed. Peptide YY (PYY) slows gastric emptying. The aim of this study was to determine fasting and nutrient-stimulated plasma PYY concentrations and their r...
Intervention: 60-minute duodenal infusion of Ensure® 2 kcal/minute Comparator: 60-minute duodenal infusion of Ensure® 1 kcal/minute, healthy subjects Outcome: cholecystokinin (CCK)
1
{"evidence_spans": [{"end": 18764, "start": 18458, "text": "ntration had returned to baseline level by 180 minutes. The magnitude of elevation in CCK concentration was greater in patients during the 2 kcal/minute infusion (AUC (0\u2013180 min): 255 \u00b1 34 versus 176 \u00b1 22 pmol/l.min, P = 0.045), but not the 1 kc...
Background It is possible to provide patients with secure access to their medical records using the Internet. Such access may assist patients in the self-management of chronic diseases such as heart failure. Objective To assess how a patient-accessible online medical record affects patient care and clinic operatio...
Intervention: SPPARO (System Providing Access to Records Online) Comparator: Control Group Outcome: The number of messages sent per patient during the first 6 months
0
{"evidence_spans": [{"end": 21131, "start": 20974, "text": "number of messages sent per patient did demonstrate a statistically significant difference when analyzed by square root transformation (p=0.02). The differen"}], "id": "11623", "pmcid": "1550594", "prompt_id": "11623", "split_group_id": "1550594", "votes": {"0...
Background It is possible to provide patients with secure access to their medical records using the Internet. Such access may assist patients in the self-management of chronic diseases such as heart failure. Objective To assess how a patient-accessible online medical record affects patient care and clinic operatio...
Intervention: SPPARO (System Providing Access to Records Online) Comparator: Control Group Outcome: The number of messages sent per patient during the second 6 months
0
{"evidence_spans": [{"end": 21188, "start": 20974, "text": "number of messages sent per patient did demonstrate a statistically significant difference when analyzed by square root transformation (p=0.02). The difference was more pronounced during the first 6 months of the i"}], "id": "11624", "pmcid": "1550594", "promp...
Background It is possible to provide patients with secure access to their medical records using the Internet. Such access may assist patients in the self-management of chronic diseases such as heart failure. Objective To assess how a patient-accessible online medical record affects patient care and clinic operatio...
Intervention: SPPARO (System Providing Access to Records Online) Comparator: Control Group Outcome: Adherence to medications
0
{"evidence_spans": [{"end": 22619, "start": 22528, "text": "e study had a power of\r\nGeneral adherence to medical advice showed significant improvement "}], "id": "11625", "pmcid": "1550594", "prompt_id": "11625", "split_group_id": "1550594", "votes": {"0": 2}}
Background It is possible to provide patients with secure access to their medical records using the Internet. Such access may assist patients in the self-management of chronic diseases such as heart failure. Objective To assess how a patient-accessible online medical record affects patient care and clinic operatio...
Intervention: SPPARO (System Providing Access to Records Online) Comparator: Control Group Outcome: General Adherence
1
{"evidence_spans": [{"end": 1178, "start": 970, "text": "controls). At 12 months, the intervention group was not found to be superior in self-efficacy (KCCQ self-efficacy score 91 vs. 85, p=0.08), but was superior in general adherence (MOS compliance score 85 vs. 7"}, {"end": 24820, "start": 24721, "text": ")\r\n69 - 6...
Background It is possible to provide patients with secure access to their medical records using the Internet. Such access may assist patients in the self-management of chronic diseases such as heart failure. Objective To assess how a patient-accessible online medical record affects patient care and clinic operatio...
Intervention: SPPARO (System Providing Access to Records Online) Comparator: Control Group Outcome: Number of visits
1
{"evidence_spans": [{"end": 1337, "start": 1259, "text": "unication. The intervention group had more emergency department visits (20 vs."}], "id": "11627", "pmcid": "1550594", "prompt_id": "11627", "split_group_id": "1550594", "votes": {"1": 1}}
Background In high-risk coronary artery bypass patients; off-pump versus on-pump surgical strategies still remain a matter of debate, regarding which method results in a lower incidence of perioperative mortality and morbidity. We describe our experience in the treatment of high-risk coronary artery patients and compa...
Intervention: off-pump surgery Comparator: on-pump surgery Outcome: left ventricular function
-1
{"evidence_spans": [{"end": 884, "start": 699, "text": "sults\r\nThose patients undergoing off-pump surgery had significantly poorer left ventricular function than those undergoing on-pump surgery (28.6 \u00b1 5.8% vs. 40.5 \u00b1 7.4%, respectively, p "}, {"end": 974, "start": 699, "text": "sults\r\nThose patients und...
Background In high-risk coronary artery bypass patients; off-pump versus on-pump surgical strategies still remain a matter of debate, regarding which method results in a lower incidence of perioperative mortality and morbidity. We describe our experience in the treatment of high-risk coronary artery patients and compa...
Intervention: off-pump surgery Comparator: on-pump surgery Outcome: Euroscore values
1
{"evidence_spans": [{"end": 974, "start": 699, "text": "sults\r\nThose patients undergoing off-pump surgery had significantly poorer left ventricular function than those undergoing on-pump surgery (28.6 \u00b1 5.8% vs. 40.5 \u00b1 7.4%, respectively, p < 0.05) and also had higher Euroscore values (7.26 \u00b1 1.4 vs. 1...
Background In high-risk coronary artery bypass patients; off-pump versus on-pump surgical strategies still remain a matter of debate, regarding which method results in a lower incidence of perioperative mortality and morbidity. We describe our experience in the treatment of high-risk coronary artery patients and compa...
Intervention: off-pump surgery Comparator: on-pump surgery Outcome: number of grafts
0
{"evidence_spans": [{"end": 1223, "start": 975, "text": "0.05). Differences between the two groups were nonsignificant with regard to number of grafts per patient, mean duration of surgery, anesthesia and operating room time, length of stay intensive care unit (ICU) and rate of postoperative atrial fibri"}, {"end": 774...
Background In high-risk coronary artery bypass patients; off-pump versus on-pump surgical strategies still remain a matter of debate, regarding which method results in a lower incidence of perioperative mortality and morbidity. We describe our experience in the treatment of high-risk coronary artery patients and compa...
Intervention: off-pump surgery Comparator: on-pump surgery Outcome: duration surgery or aortic cross-clamp time
0
{"evidence_spans": [{"end": 7987, "start": 7748, "text": "mp and on-pump patients (2.03 \u00b1 0.7 vs.1.99 \u00b1 0.6 grafts per patient respectively, p = 0.15). Nor were there any significant differences between on-and off pump patients with regard to duration surgery (105 \u00b1 22 vs. 80 \u00b1 25, respectively, "},...
Background In high-risk coronary artery bypass patients; off-pump versus on-pump surgical strategies still remain a matter of debate, regarding which method results in a lower incidence of perioperative mortality and morbidity. We describe our experience in the treatment of high-risk coronary artery patients and compa...
Intervention: off-pump surgery Comparator: on-pump surgery Outcome: low cardiac output syndrome (LCOS)
0
{"evidence_spans": [{"end": 9047, "start": 8894, "text": " with no significant difference between the 2 groups. We could not show any significant difference between the off-pump and on-pump patients. Three (7.5%"}], "id": "11632", "pmcid": "1224861", "prompt_id": "11632", "split_group_id": "1224861", "votes": {"0": 2}}
Background In high-risk coronary artery bypass patients; off-pump versus on-pump surgical strategies still remain a matter of debate, regarding which method results in a lower incidence of perioperative mortality and morbidity. We describe our experience in the treatment of high-risk coronary artery patients and compa...
Intervention: off-pump surgery Comparator: on-pump surgery Outcome: Postoperative mortality
0
{"evidence_spans": [{"end": 10212, "start": 10069, "text": "or the off-pump patients and 7 \u00b1 2 days for on-pump patients (p = 0.48).\r\n\r\nPostoperative mortality\r\nWe defined postoperative mortality as deat"}], "id": "11633", "pmcid": "1224861", "prompt_id": "11633", "split_group_id": "1224861", "votes": {"0": ...
Background “FFM ME-TRAP” is sequential immunisation with two attenuated poxvirus vectors (FP9 and modified vaccinia virus Ankara) delivering the pre-erythrocytic malaria antigen ME-TRAP. Over nine months follow-up in our original study, there was no evidence that FFM ME-TRAP provided protection against malaria. The in...
Intervention: ME-TRAP (the Multiple Epitope string and Thrombospondin Related Adhesion Protein, ME- TRAP [2]) Comparator: control Outcome: Survival
0
{"evidence_spans": [{"end": 11807, "start": 11567, "text": " (0.39\u20131.34, p\u200a=\u200a0.31) for the full 18 months, first 9 months and second 9 months monitoring, respectively. The difference in HRs between the two time periods was not statistically significant (the likelihood ratio test for the interaction "}], ...
In the Edinburgh Randomised Breast Screening Project (EBSP) to December 1988 there were 500 cancers in the study population invited to screening and 340 cancers identified in the control population. The size and negative lymph node status characteristics of invasive cancers from the two populations were significantly d...
Intervention: Edinburgh Randomised Breast Screening Project (EBSP) Comparator: control Outcome: Ability to detect 'early stages', and noninvasive forms of cancer
1
{"evidence_spans": [{"end": 608, "start": 199, "text": "The size and negative lymph node status characteristics of invasive cancers from the two populations were significantly different (P less than 0.05). The cancers detected by screening were predominantly 'early stage', with 16% noninvasive (PTIS) and 42% invasive s...
In the Edinburgh Randomised Breast Screening Project (EBSP) to December 1988 there were 500 cancers in the study population invited to screening and 340 cancers identified in the control population. The size and negative lymph node status characteristics of invasive cancers from the two populations were significantly d...
Intervention: Edinburgh Randomised Breast Screening Project (EBSP) Comparator: control Outcome: Ability to detect poor survival probability group
1
{"evidence_spans": [{"end": 1451, "start": 1143, "text": "When these same histological characteristics were used to compare survival, the capacity to separate invasive cancers into two groups having good and poor survival probabilities was evident, with a significant improvement for the screen detected poor survival gr...
In the Edinburgh Randomised Breast Screening Project (EBSP) to December 1988 there were 500 cancers in the study population invited to screening and 340 cancers identified in the control population. The size and negative lymph node status characteristics of invasive cancers from the two populations were significantly d...
Intervention: Edinburgh Randomised Breast Screening Project (EBSP) Comparator: control Outcome: Ability to detect patients with positive lymph node biopsy
0
{"evidence_spans": [{"end": 837, "start": 608, "text": " Grouped according to customary size ranges of invasive cancers, the proportion of cases lymph node positive differed in those screen detected compared with controls, but the benefit in favour of screen detection was not constant"}, {"end": 838, "start": 609, "tex...
Background This study was designed to evaluate the effects of a 24-month period of moderate exercise on serum lipids in menopausal women. Methods The subjects (40–60 y) were randomly divided into an exercise group (n = 14) and a control group (n = 13). The women in the exercise group were asked to participate in a...
Intervention: 24-month period of moderate exercise Comparator: control Outcome: high-density lipoprotein cholesterol (HDLC)
1
{"evidence_spans": [{"end": 12591, "start": 12484, "text": "HDLC (F = 4.08, P < 0.05) and TC : HDLC ratio (F = 4.27, P < 0.05) could be observed. HDLC at 24 months in "}, {"end": 12592, "start": 12485, "text": "DLC (F = 4.08, P < 0.05) and TC : HDLC ratio (F = 4.27, P < 0.05) could be observed. HDLC at 24 months in t"}...
Background This study was designed to evaluate the effects of a 24-month period of moderate exercise on serum lipids in menopausal women. Methods The subjects (40–60 y) were randomly divided into an exercise group (n = 14) and a control group (n = 13). The women in the exercise group were asked to participate in a...
Intervention: 24-month period of moderate exercise Comparator: control Outcome: total cholesterol (TC) : HDLC ratio
-1
{"evidence_spans": [{"end": 12734, "start": 12593, "text": "e exercise group was significantly higher (P < 0.05) than that in the control group. In the exercise group, TC : HDLC ratio at 24 months in t"}], "id": "11647", "pmcid": "65683", "prompt_id": "11647", "split_group_id": "65683", "votes": {"-1": 2}}
Background In Italy many diabetics still lack adequate care in general practice. We assessed the effectiveness of different strategies for the implementation of an evidence-based guideline for the management of non-complicated type 2 diabetes among General Practitioners (GPs) of Lazio region. Methods Three-arm clu...
Intervention: active strategy (training module with administration of the guideline) Comparator: usual care (control) Outcome: metabolic control indicator, macrovascular complications assessment tests, microvascular complications assessment tests
0
{"evidence_spans": [{"end": 20410, "start": 20108, "text": "\r\n0,93\r\n(0,67 \u2013 1,30)\r\n\r\nUsual care\r\n10,3 %\r\n\r\n1\r\n\r\nMacrovascular complications\r\nActive implementation\r\n14,0 %\r\n0,054\r\n1,07\r\n(0,80 \u2013 1,43)\r\n\r\nPassive dissemination\r\n11,7 %\r\n\r\n0,93\r\n(0,70 \u2013 1,24)\r\n\r\nUsu...
Background The combination of inhaled corticosteroids (ICS) and long-acting β2-agonists (LABA) is recommended by treatment guidelines for the treatment of persistent asthma. Two such combination products, salmeterol/fluticasone propionate (SFC, Seretide™ GSK, UK) and formoterol/budesonide (FBC, Symbicort™, AstraZeneca...
Intervention: formoterol/budesonide (FBC, Symbicort™, AstraZeneca, UK) Comparator: placebo Outcome: forced expiratory volume in one second (FEV1)
1
{"evidence_spans": [{"end": 1622, "start": 1305, "text": "\nResults\r\nIn study A, a single inhalation of SFC and FBC produced a sustained bronchodilation at 16 hours with an adjusted mean increase in FEV1 from pre-dose of 0.22 L (95% CI 0.19, 0.35 L) for SFC and 0.25 L (95% CI 0.21, 0.37 L) for FBC, which was signific...
Background The combination of inhaled corticosteroids (ICS) and long-acting β2-agonists (LABA) is recommended by treatment guidelines for the treatment of persistent asthma. Two such combination products, salmeterol/fluticasone propionate (SFC, Seretide™ GSK, UK) and formoterol/budesonide (FBC, Symbicort™, AstraZeneca...
Intervention: formoterol/budesonide (FBC, Symbicort™, AstraZeneca, UK) Comparator: salmeterol/fluticasone propionate (SFC, Seretide™ GSK, UK) Outcome: the median number of days with no use of relief medication
0
{"evidence_spans": [{"end": 15330, "start": 15067, "text": "an FEV1 measurements over 24 hours after the first dose of regular treatment with SFC (50/100 mcg bd) and FBC (4.5/160 mcg bd) (study B).\r\nFor diary card parameters, the adjusted mean change from baseline in morning PEF was 25 L/min in both the SFC and FBC g...
Background The combination of inhaled corticosteroids (ICS) and long-acting β2-agonists (LABA) is recommended by treatment guidelines for the treatment of persistent asthma. Two such combination products, salmeterol/fluticasone propionate (SFC, Seretide™ GSK, UK) and formoterol/budesonide (FBC, Symbicort™, AstraZeneca...
Intervention: formoterol/budesonide (FBC, Symbicort™, AstraZeneca, UK) Comparator: salmeterol/fluticasone propionate (SFC, Seretide™ GSK, UK) Outcome: the median number of nights with no use of relief medication
0
{"evidence_spans": [{"end": 15330, "start": 15067, "text": "an FEV1 measurements over 24 hours after the first dose of regular treatment with SFC (50/100 mcg bd) and FBC (4.5/160 mcg bd) (study B).\r\nFor diary card parameters, the adjusted mean change from baseline in morning PEF was 25 L/min in both the SFC and FBC g...
Background Obstructive sleep apnea (OSA) is a prevalent and serious medical condition characterized by repeated complete or partial obstructions of the upper airway during sleep and is prevalent in 2% to 4% of working middle-aged adults. Nasal continuous positive airway pressure (CPAP) is the gold-standard treatment ...
Intervention: telemonitored clinical care (TCC) Comparator: usual clinical care Outcome: used CPAP( hours per night)
0
{"evidence_spans": [{"end": 29336, "start": 29131, "text": "iod (number days monitored)\r\n59.6 \u00b1 4.0\r\n43-63\r\n60 \u00b1 3.0\r\n51-63\r\n60.2 \u00b1 2.8\r\n55-63\r\n.26\r\n\r\n *\r\n t test comparing TCC vs UCC\r\nCPAP Compliance\r\nParticipa"}, {"end": 2933...
Background Obstructive sleep apnea (OSA) is a prevalent and serious medical condition characterized by repeated complete or partial obstructions of the upper airway during sleep and is prevalent in 2% to 4% of working middle-aged adults. Nasal continuous positive airway pressure (CPAP) is the gold-standard treatment ...
Intervention: telemonitored clinical care (TCC) Comparator: usual clinical care Outcome: Apnea-Hypopnea Index
0
{"evidence_spans": [{"end": 31915, "start": 31185, "text": ".18\r\n0.17-0.82\r\n0.50 \u00b1 0.47\r\n0.1-2.2\r\n.31\r\nMask leak, maximum (L/s)\r\n0.71 \u00b1 .41\r\n0.1-2.2\r\n0.68 \u00b1 0.25\r\n0.26-1.4\r\n0.75 \u00b1 0.54\r\n0.1-2.2\r\n.62\r\n\r\n *\r\n t...
Background Obstructive sleep apnea (OSA) is a prevalent and serious medical condition characterized by repeated complete or partial obstructions of the upper airway during sleep and is prevalent in 2% to 4% of working middle-aged adults. Nasal continuous positive airway pressure (CPAP) is the gold-standard treatment ...
Intervention: telemonitored clinical care (TCC) Comparator: usual clinical care Outcome: Patients rated their likelihood to continue using CPAP
1
{"evidence_spans": [{"end": 1679, "start": 1534, "text": "ea Index. Patients in the telemonitored group rated their likelihood to continue using CPAP significantly higher than the patients in the usual c"}, {"end": 33560, "start": 33426, "text": "2 \u00b1 5.0\r\n1.8-19.8\r\n14.4 \u00b1 4.2\r\n1.8-19.9\r\n.61\r\nCenter ...
Background Nutrilon Omneo (new formula; NF) contains high concentration of sn-2 palmitic acid, a mixture of prebiotic oligosaccharides and partially hydrolyzed whey protein. It is hypothesized that NF positively affects stool characteristics in constipated infants. Methods Thirty-eight constipated infants, aged 3–...
Intervention: Nutrilon Omneo (new formula; NF) Comparator: standard formula Outcome: defecation frequency
0
{"evidence_spans": [{"end": 912, "start": 680, "text": "nfants. A significant increase in defecation frequency (NF: 3.5 pre versus 5.6/week post treatment; SF 3.6 pre versus 4.9/week post treatment) was found in both groups, but was not significantly different between the two formulas (p"}, {"end": 914, "start": 681, "...
Background Nutrilon Omneo (new formula; NF) contains high concentration of sn-2 palmitic acid, a mixture of prebiotic oligosaccharides and partially hydrolyzed whey protein. It is hypothesized that NF positively affects stool characteristics in constipated infants. Methods Thirty-eight constipated infants, aged 3–...
Intervention: Nutrilon Omneo (new formula; NF) Comparator: standard formula Outcome: Improvement of hard stool consistency to soft stool consistency
0
{"evidence_spans": [{"end": 1112, "start": 914, "text": " 0.36). Improvement of hard stool consistency to soft stool consistency was found more often with NF than SF, but did not reach statistical significance (90% versus 50%; RR, 1.8; 95% CI, 0.9\u20133.5; p "}, {"end": 13300, "start": 13063, "text": " post treatment ...
Background Nutrilon Omneo (new formula; NF) contains high concentration of sn-2 palmitic acid, a mixture of prebiotic oligosaccharides and partially hydrolyzed whey protein. It is hypothesized that NF positively affects stool characteristics in constipated infants. Methods Thirty-eight constipated infants, aged 3–...
Intervention: Nutrilon Omneo (new formula; NF) Comparator: standard formula Outcome: painful defecation
0
{"evidence_spans": [{"end": 12377, "start": 12346, "text": "\r\n0\u201320\r\n0\u20136\r\n\r\nDefecation frequ"}, {"end": 14867, "start": 14737, "text": "igher in the NF period, with 17% (n = 4) of infants having soft stools when receiving NF but hard stools with SF, compared to no i"}], "id": "11666", "pmcid": "1852321...
Background Nutrilon Omneo (new formula; NF) contains high concentration of sn-2 palmitic acid, a mixture of prebiotic oligosaccharides and partially hydrolyzed whey protein. It is hypothesized that NF positively affects stool characteristics in constipated infants. Methods Thirty-eight constipated infants, aged 3–...
Intervention: Nutrilon Omneo (new formula; NF) Comparator: standard formula Outcome: The frequency of soft stools
1
{"evidence_spans": [{"end": 14735, "start": 14466, "text": "mpleted the cross-over study. In these infants, the defecation frequency was comparable for NF and SF with a mean frequency of 5.5/week vs. 5.9/week (Difference of means, - 0.5; 95% CI, -1,6 \u2013 0,6; p = 0.38), respectively. The frequency of soft stools was...
Interleukin-11 (IL-11) is a pleiotropic cytokine that regulates the growth and development of hematopoietic stem cells and decreases the proinflammatory mediators of cytokine and nitric oxide production. In animal models of arthritis, treatment with recombinant human IL-11 (rhIL-11) reduces both the level of synovitis ...
Intervention: recombinant human IL-11 (rhIL-11) Comparator: placebo Outcome: number of tender joints
-1
{"evidence_spans": [{"end": 1529, "start": 1432, "text": "te. The data suggest a statistically significant reduction in the number of tender joints (P < 0."}, {"end": 1654, "start": 1433, "text": "e. The data suggest a statistically significant reduction in the number of tender joints (P < 0.008) at the 15 \u03bcg/kg o...
Interleukin-11 (IL-11) is a pleiotropic cytokine that regulates the growth and development of hematopoietic stem cells and decreases the proinflammatory mediators of cytokine and nitric oxide production. In animal models of arthritis, treatment with recombinant human IL-11 (rhIL-11) reduces both the level of synovitis ...
Intervention: recombinant human IL-11 (rhIL-11) Comparator: placebo Outcome: incidence of infection
0
{"evidence_spans": [{"end": 12726, "start": 12582, "text": "espiratory infections, or edema. A higher incidence of infection in the rhIL-11 treated group (7.8%) than in the placebo group (0%) was not stat"}], "id": "11669", "pmcid": "34114", "prompt_id": "11669", "split_group_id": "34114", "votes": {"0": 2}}
Interleukin-11 (IL-11) is a pleiotropic cytokine that regulates the growth and development of hematopoietic stem cells and decreases the proinflammatory mediators of cytokine and nitric oxide production. In animal models of arthritis, treatment with recombinant human IL-11 (rhIL-11) reduces both the level of synovitis ...
Intervention: recombinant human IL-11 (rhIL-11) Comparator: placebo Outcome: fibrinogen levels, platelet counts
0
{"evidence_spans": [{"end": 13266, "start": 13084, "text": "ters were noted during the study. There were no statistically significant changes in fibrinogen levels or platelet counts in rhIL-11 treated patients compared with placebo during the"}], "id": "11670", "pmcid": "34114", "prompt_id": "11670", "split_group_id": ...
Background Biometric procedures such as keratometry performed shortly after contact procedures like gonioscopy and applanation tonometry could affect the validity of the measurement. This study was conducted to understand the short-term effect of gonioscopy on corneal curvature measurements and surface topography base...
Intervention: Sim K , using both the Goldmann and the Sussman Comparator: baseline Outcome: steepening
1
{"evidence_spans": [{"end": 10744, "start": 10590, "text": " The change in K is measured on the y-axis and the time of measuring changes on the x-axis.\r\nThe results show a significant steepening in Sim K up to the "}], "id": "11671", "pmcid": "1550259", "prompt_id": "11671", "split_group_id": "1550259", "votes": {"1"...
Background Biometric procedures such as keratometry performed shortly after contact procedures like gonioscopy and applanation tonometry could affect the validity of the measurement. This study was conducted to understand the short-term effect of gonioscopy on corneal curvature measurements and surface topography base...
Intervention: Auto-Keratometry Comparator: Sim K Outcome: effects produced between the gonioscopes
0
{"evidence_spans": [{"end": 10930, "start": 10745, "text": "irst 15 minutes using both the Goldmann (p = 0.002) and the Sussman (p = 0.004) gonioscopes. There were no significant differences in the effects produced between the gonioscopes at any"}], "id": "11672", "pmcid": "1550259", "prompt_id": "11672", "split_group_...
Objectives The purpose of this study was to assess the ability of ProTaper Gold (PTG, Dentsply Maillefer) in maintaining the original profile of root canal anatomy. For that, ProTaper Universal (PTU, Dentsply Maillefer) was used as reference techniques for comparison. Materials and Methods Twenty simulated curved ...
Intervention: ProTaper Universal (PTU, Dentsply Maillefer) Comparator: ProTaper Gold (PTG, Dentsply Maillefer) Outcome: canal transportation at the straight part
0
{"evidence_spans": [{"end": 1171, "start": 1093, "text": "found. PTU and PTG systems produced similar canal transportation at the straig"}, {"end": 1172, "start": 1093, "text": "found. PTU and PTG systems produced similar canal transportation at the straigh"}], "id": "11678", "pmcid": "4751201", "prompt_id": "11678", "...
Objectives The purpose of this study was to assess the ability of ProTaper Gold (PTG, Dentsply Maillefer) in maintaining the original profile of root canal anatomy. For that, ProTaper Universal (PTU, Dentsply Maillefer) was used as reference techniques for comparison. Materials and Methods Twenty simulated curved ...
Intervention: ProTaper Universal (PTU, Dentsply Maillefer) Comparator: ProTaper Gold (PTG, Dentsply Maillefer) Outcome: canal transportation at the curved part
1
{"evidence_spans": [{"end": 1338, "start": 1173, "text": " part, while PTG system resulted in lower canal transportation than PTU system at the curved part. Canal transportation was higher at the curved canal portion (p < 0"}, {"end": 1337, "start": 1178, "text": ", while PTG system resulted in lower canal transportati...
Background We evaluated whether the addition of a small dose of ketamine or fentanyl would lead to a reduction in the total dose of propofol consumed without compromising the safety and recovery of patients having endoscopic ultrasonography (EUS). Methods A total of 210 adult patients undergoing elective EUS under...
Intervention: 50 µg fentanyl in group 2, Comparator: 0.5 mg/kg ketamine in group 3 Outcome: The amount of propofol consumed
0
{"evidence_spans": [{"end": 10215, "start": 10106, "text": " = 0.024) or group 3 (P < 0.001). However, there was no significant difference in propofol consumption betwee"}, {"end": 10214, "start": 10114, "text": ") or group 3 (P < 0.001). However, there was no significant difference in propofol consumption betwe"}], "i...
Background We evaluated whether the addition of a small dose of ketamine or fentanyl would lead to a reduction in the total dose of propofol consumed without compromising the safety and recovery of patients having endoscopic ultrasonography (EUS). Methods A total of 210 adult patients undergoing elective EUS under...
Intervention: 0.5 mg/kg ketamine in group 3 Comparator: 50 µg fentanyl in group 2, normal saline in group 1 Outcome: the time to achieve a maximum PADS of 10
1
{"evidence_spans": [{"end": 1212, "start": 1110, "text": "roups. The time to achieve a PADS of 10 was significantly higher in group 3 compared to the other two "}, {"end": 10623, "start": 10360, "text": "d when ANOVA was used (P < 0.001). On further intergroup analysis, it was observed that this was longest in group 3,...
Background We evaluated whether the addition of a small dose of ketamine or fentanyl would lead to a reduction in the total dose of propofol consumed without compromising the safety and recovery of patients having endoscopic ultrasonography (EUS). Methods A total of 210 adult patients undergoing elective EUS under...
Intervention: normal saline in group 1 Comparator: 50 µg fentanyl in group 2, Outcome: the time to achieve a maximum PADS of 10
0
{"evidence_spans": [{"end": 10730, "start": 10624, "text": " \u00b1 13.9 min, P < 0.001) (Table 2). There was no difference in the time taken to achieve a PADS of 10 betwe"}], "id": "11683", "pmcid": "5809707", "prompt_id": "11683", "split_group_id": "5809707", "votes": {"0": 2}}
Background We evaluated whether the addition of a small dose of ketamine or fentanyl would lead to a reduction in the total dose of propofol consumed without compromising the safety and recovery of patients having endoscopic ultrasonography (EUS). Methods A total of 210 adult patients undergoing elective EUS under...
Intervention: normal saline in group 1 Comparator: 50 µg fentanyl in group 2, and 0.5 mg/kg ketamine in group 3 Outcome: the mean blood pressure, heart rate, or SpO2
0
{"evidence_spans": [{"end": 11020, "start": 10807, "text": " were analyzed at 5-min intervals. Overall, patient hemodynamics and oxygenation were comparable in all groups. There were no significant differences in the mean blood pressure, heart rate, or SpO2 at any time poi"}, {"end": 11020, "start": 10884, "text": "ion...
Background We evaluated whether the addition of a small dose of ketamine or fentanyl would lead to a reduction in the total dose of propofol consumed without compromising the safety and recovery of patients having endoscopic ultrasonography (EUS). Methods A total of 210 adult patients undergoing elective EUS under...
Intervention: normal saline in group 1 Comparator: 50 µg fentanyl in group 2, and 0.5 mg/kg ketamine in group 3 Outcome: incidence of desaturation, hypotension, coughing, or hiccups
0
{"evidence_spans": [{"end": 11190, "start": 11021, "text": "t among the three groups (Fig. 1). There were also no differences in the incidence of desaturation (P = 0.922), hypotension (P = 0.880), coughing (P = 0.269), or hiccups"}, {"end": 11201, "start": 11021, "text": "t among the three groups (Fig. 1). There were a...
Background We evaluated whether the addition of a small dose of ketamine or fentanyl would lead to a reduction in the total dose of propofol consumed without compromising the safety and recovery of patients having endoscopic ultrasonography (EUS). Methods A total of 210 adult patients undergoing elective EUS under...
Intervention: normal saline in group 1 Comparator: 50 µg fentanyl in group 2, and 0.5 mg/kg ketamine in group 3 Outcome: difference in operator feasibility
0
{"evidence_spans": [{"end": 11643, "start": 11542, "text": "all or memory after the procedure. There was no difference in operator feasibility in the groups as r"}, {"end": 11654, "start": 11542, "text": "all or memory after the procedure. There was no difference in operator feasibility in the groups as rated by the"}]...
Background Artistic Gymnastics is a sport where athletes are frequently fatigued. One element that might influence this aspect is carbohydrate, an important energy substrate for the muscles and the CNS. Our goal was to investigate the influence of fatigue over artistic gymnastics athlete’s performance and the effects ...
Intervention: FG (fatigue group) did a fatigue circuit, warm up exercises and then the experimental protocol Comparator: CG (control group) warmed up before the experimental protocol Outcome: WATER DAY the number of falls
1
{"evidence_spans": [{"end": 17005, "start": 16796, "text": "r of falls observed during the execution of the experimental sets on the balance beam. On WATER DAY the number of falls was statistically higher to FG than CG (5.4\u2009\u00b1\u20091.14 FG and 3.33\u2009\u00b1\u20091.37 CG p\u2009=\u20090.02) demons"}, {"end":...
Objective: This study examines the effect of the addition of IMOD, a novel multi-herbal drug to the highly active anti-retroviral therapy (HAART) regimen, on the immunological status of HIV-positive patients. Materials and Methods: A randomized two-parallel-group (HAART group versus HAART+IMOD group), pretest-post...
Intervention: HAART regimen plus Immune-Modulator Drug (IMOD) every day for 3 months Comparator: control group - only the HAART regimen every day for 3 months. Outcome: the mean difference of total lymphocyte count (TLC)
0
{"evidence_spans": [{"end": 1070, "start": 968, "text": "erapy. The difference in TLC was not significantly different between the two groups before and after t"}, {"end": 13730, "start": 13481, "text": "no significant difference between the two groups in terms of TLC mean in baseline (p=0.403). Based on Wilcoxon test, ...
Objective: This study examines the effect of the addition of IMOD, a novel multi-herbal drug to the highly active anti-retroviral therapy (HAART) regimen, on the immunological status of HIV-positive patients. Materials and Methods: A randomized two-parallel-group (HAART group versus HAART+IMOD group), pretest-post...
Intervention: HAART regimen plus Immune-Modulator Drug (IMOD) every day for 3 months Comparator: control group - only the HAART regimen every day for 3 months. Outcome: CD4 cell count
1
{"evidence_spans": [{"end": 12173, "start": 11860, "text": "rms of CD4 mean in baseline (p=0.06). In the intervention group, the mean differences of CD4 before and after drug therapy showed a significant difference (mean difference=172.3, p=0.001). However, in the control group, the mean differences of CD4 before and a...
Background Many patients with IBS suffer on-going symptoms. The evidence base is poor for IBS drugs but they are widely prescribed and advised in Guidelines. Cognitive Behavioural Therapy (CBT) can be helpful, but availability is poor in the NHS. We developed a web-based CBT self-management programme (Regul8) in partn...
Intervention: over-encapsulated mebeverine, methylcellulose Comparator: placebo Outcome: IBS SSS or IBS-QOL
0
{"evidence_spans": [{"end": 1138, "start": 1038, "text": "weeks. There was no significant difference in IBS SSS or IBS-QOL score between medication or website"}, {"end": 24756, "start": 24600, "text": "35 points from baseline to the 12\u00a0week point. The mean of the IBS-QOL score of the sample increased (positive cha...
Background Many patients with IBS suffer on-going symptoms. The evidence base is poor for IBS drugs but they are widely prescribed and advised in Guidelines. Cognitive Behavioural Therapy (CBT) can be helpful, but availability is poor in the NHS. We developed a web-based CBT self-management programme (Regul8) in partn...
Intervention: nurse telephone session and email support, minimal email support Comparator: no website Outcome: Irritable Bowel Syndrome Quality of Life (IBS-QOL)
0
{"evidence_spans": [{"end": 2268, "start": 1943, "text": "rger trial. Primary outcomes (IBS SS and IBS QOL) did not reach significance at 6 or 12\u00a0weeks, apart from IBS SSS being lower in the no-website group at 6\u00a0weeks - this disappeared by 12\u00a0weeks. Improved Enablement suggests patients with access to t...
Background Many patients with IBS suffer on-going symptoms. The evidence base is poor for IBS drugs but they are widely prescribed and advised in Guidelines. Cognitive Behavioural Therapy (CBT) can be helpful, but availability is poor in the NHS. We developed a web-based CBT self-management programme (Regul8) in partn...
Intervention: nurse telephone session and email support, minimal email support Comparator: no website Outcome: Irritable Bowel Syndrome (IBS) Severity Scoring System (IBS-SSS)
1
{"evidence_spans": [{"end": 25144, "start": 24765, "text": "5 points from baseline to the 12\u00a0week point (Figures\u00a02 and 3).\r\nFigure 2IBS symptom severity score at baseline, six and twelve weeks by website group.\r\nFigure 3IBS symptom severity score at baseline, six and twelve weeks by medicine group.\r\nAt ...
Abstract Background The increasing use of ketamine as a potential rapid-onset antidepressant necessitates a better understanding of its effects on blood pressure and heart rate, well-known side effects at higher doses. For the subanesthetic dose used for depression, potential predictors of these cardiovascular effect...
Intervention: ketamine group Comparator: placebo group Outcome: Systolic arterial blood pressure (RR)
1
{"evidence_spans": [{"end": 19291, "start": 19089, "text": "e in the supplementary material (supplementary Figure 5).\r\nFigure 1.Systolic blood pressure during ketamine and placebo infusion, separately to show boxplot. Systolic blood pressure was higher in the ke"}, {"end": 19291, "start": 19098, "text": "supplementar...
Abstract Background The increasing use of ketamine as a potential rapid-onset antidepressant necessitates a better understanding of its effects on blood pressure and heart rate, well-known side effects at higher doses. For the subanesthetic dose used for depression, potential predictors of these cardiovascular effect...
Intervention: ketamine group Comparator: placebo group Outcome: Diastolic blood pressure
1
{"evidence_spans": [{"end": 1405, "start": 1250, "text": "esults\r\nSystolic and diastolic blood pressure as well as heart rate increased significantly upon ketamine administration, but without reaching hypertensive"}, {"end": 19513, "start": 19392, "text": " ketamine and placebo infusion, separately to show boxplot. D...
Abstract Background The increasing use of ketamine as a potential rapid-onset antidepressant necessitates a better understanding of its effects on blood pressure and heart rate, well-known side effects at higher doses. For the subanesthetic dose used for depression, potential predictors of these cardiovascular effect...
Intervention: ketamine group women Comparator: ketamine group men Outcome: The maximal change in the curve during the observation period (ΔMAX)
1
{"evidence_spans": [{"end": 23347, "start": 23016, "text": "ntary Figure 7). To reveal what drives the time by gender interaction, we split the sample according to group. There was a highly significant time by gender interaction in the ketamine group (F5.520,176.630=3.279, Greenhouse-Geisser correction applied, P=.005,...